Browse All Trials

  • Isotretinoin With or Without Dinutuximab, Aldesleukin, and Sargramostim Following Stem Cell Transplant in Treating Patients With Neuroblastoma
  • Radiation Therapy With Either Capecitabine or Fluorouracil Before Surgery in Treating Patients With Resectable Rectal Cancer (NSABP-R-04)
  • Combination Chemotherapy and Cyclosporine Followed by Focal Therapy for Bilateral Retinoblastoma
  • Positron Emission Tomography Scanning and Epstein-Barr Virus DNA Levels in the Staging and Follow-Up of Nasopharyngeal Carcinoma.
  • Treatment of Children With Newly Diagnosed Acute Lymphoblastic Leukemia (ALL)
  • A Study of Intensity Modulated Radiation Therapy for Pelvic Lymph Nodes and Primary Tumour in Patients with Prostate Cancer
  • Safety Study of the Proteasome Inhibitor PR-171 in Patients With Hematological Malignancies (PX-171)
  • 3D-Conformal Radiation vs Helical Tomotherapy in Prostate Cancer
  • Combination Chemotherapy Followed By Donor Stem Cell Transplant in Treating Patients With Hemophagocytic Lymphohistiocytosis (EU-20619)
  • Paclitaxel and Carboplatin With or Without Celecoxib Before Surgery in Treating Patients With Stage IIIA Non-Small Cell Lung Cancer
  • CPT-11 (Irinotecan), Oxaliplatin and Xeloda (COX) in Patients with Advanced Colorectal Cancer
  • Collecting and Banking Pediatric Brain Tumour Research Specimens
  • Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed Stage III or Stage IV Wilms' Tumour
  • Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Rhabdomyosarcoma
  • A Phase I/II Study of Concurrent Pemetrexed/Cisplatin/Radiation in Stage IIIA/B Non-Small Cell Lung Cancer
  • Adjunctive Efficacy Study Of The SoftScan® Optical Breast Imaging System
  • Reduced Intensity Conditioning Transplantation Versus Standard of Care in Acute Myeloid Leukemia
  • The Effect of Radiation on Semen Quality and Fertility in Men With Prostate Cancer
  • Dynamic Breast MRI in Assessing Locally Advanced Breast Cancer
  • A Pilot Study To Evaluate the Effectiveness of Pulsed Time-Domain Optical Spectroscopy for Monitoring the Responses in Neoadjuvant Treatments of Locally-Advanced Breast Cancer
  • Pilot Investigation of Ultrasound Imaging and Spectroscopy and Ultrasound Imaging of Vascular Blood Flow as Early Indicators of Locally-Advanced Breast Cancer Response to Neoadjuvant Treatment
  • Stereotactic Radiation Therapy With or Without Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases
  • Radiation Therapy and Androgen Deprivation Therapy in Treating Patients Who Have Undergone Surgery for Prostate Cancer (RADICALS)
  • Prostate Radiation Therapy or Short-Term Androgen Deprivation Therapy and Pelvic Lymph Node Radiation Therapy With or Without Prostate Radiation Therapy in Treating Patients With a Rising Prostate Specific Antigen (PSA) After Surgery for Prostate Cancer
  • Iodine I 131 Metaiodobenzylguanidine and a Stem Cell Transplant in Treating Young Patients With Relapsed or Refractory High-Risk Neuroblastoma
  • Exploring the Role of 3T MRI in Gamma Knife Radiosurgery
  • Randomized Phase III Study of Optimal Sequencing of Hormonal Therapy and Radiation in Patients with T1-T3 Prostate Cancer
  • Does Palliative Chemotherapy Improve Symptoms in Women with Recurrent Ovarian Cancer?
  • Study of Antioxidants on MRI Detectable Early Stage Prostate Cancer Among Men on Active Surveillance
  • Pap Smear Research Study
  • Temozolomide and Oral VP-16
  • Comparison of Different Types of Surgery in Treating Patients With Stage IA Non-Small Cell Lung Cancer
  • Adjuvant Melatonin for Prevention of Lung Cancer Recurrence and Mortality
  • MRI-Guided Biopsy of Recurrent Prostate Cancer After Radiation Therapy
  • Using Bio Markers to Predict Disease Recurrence and Cognitive Function in High Risk Breast Ca
  • Clinical Trial of Ridaforolimus Compared to Progestin or Chemotherapy for Advanced Endometrial Carcinoma (8669-007)
  • Surgery With or Without Docetaxel and Leuprolide or Goserelin in Treating Patients With High-Risk Localized Prostate Cancer
  • A Dose Escalation Study of MK1775 in Combination With Either Gemcitabine, Cisplatin, or Carboplatin in Adults With Advanced Solid Tumours (MK-1775-001 AM7)
  • Neuropsychological and Behavioural Testing in Younger Patients With Cancer
  • Online Psychoeducational Intervention Program
  • TEM Prostate
  • Short Neoadjuvant Hemithoracic IMRT for MPM
  • Sorafenib Long Term Extension Program (STEP)
  • Phase 1 Study Evaluating the Integration of Hypofractional Renal Ablative Radiation Therapy in the Setting of Metastatic Renal Cell Carcinoma
  • The Effects of Chemotherapy on Cognition
  • Does Performing a Confirmatory Tumour Biopsy in Patients with Metastatic Breast Cancer Alter their Management?
  • DCIS Permanent Breast Seed Implant
  • Health Education Materials With or Without a Physical Activity Program for Patients Who Have Undergone Treatment for High-Risk Stage II or Stage III Colon Cancer
  • Study Of Sunitinib In Patients With Recurrent Paraganglioma/Pheochromocytoma
  • Study of Antioxidants on Prostate Tumours in Men Undergoing Radical Prostatectomy for Prostate Cancer
  • A Pilot Study of Gentiana lutea (radix), Zingiber officinalis, and Curcuma longa for the Treatment of Anorexia in Cancer Patients
  • Sterotactic Body Radiation Therapy for Unresectable Liver Metastases from Colorectal Cancer
  • Sterotactic Body Radiation Therapy for Unresectable Hepatocellular Cancer
  • Pharmacogenetic Study of Irinotecan Chemotherapy
  • A Phase II Study of Dexamethasone in the Prophylaxis of Radiation-Induced Pain Flare
  • Sorafenib in patients with metastatic Renal Cell cancer resistant to Sutent
  • Busulfan and Fludarabine as Conditioning for Allogeneic Stem Cell Transplantation: a Pharmacokinetic Study
  • Study of Late-Occurring Complications in Childhood Cancer Survivors
  • Acetaminophen for Cancer Pain
  • Chemotherapy and Radiation Therapy Compared With Radiation Therapy Alone in Treating Patients With High-Risk Stage I, Stage II, or Stage III Endometrial Cancer
  • Community Based Exercise Program for Well Cancer Survivors
  • Stereotactic Body Radiation Therapy (SBRT) in the Treatment of Liver Tumours
  • Prospective Identification of Risk Factors for Skeletal Related Events in Breast Cancer Patients Receiving Bisphosphonates for Bone Metastases
  • Reform: A Randomised Pilot Study Comparing the Efficacy of 4-weekly versus 12-weekly intravenous Bisphosphonate Therapy in Women with low risk Bone Metastases from Breast Cancer using bone resorption markers
  • Identification of Clinically Occult Glioma Cells and Characterization of Glioma Behaviour Through Machine Learning Analysis of Advanced Imaging Technology
  • Imaging Study in Patients With Cancer of the Head & Neck, Lung, Renal Cell, Brain, Lymphoma and Neuroendocrine Tumours
  • Effect of an Oral Supplement on the Total Energy and Protein Intake of Head and Neck Cancer Patients in the Last 2 Weeks of Radiation Therapy
  • Phase II Study of IMRT With SIB as Adjuvant Treatment for High Risk Resected Well-differentiated Thyroid Cancer.
  • Complete Lymph Node Dissection or Observation in Treating Patients With Localized Melanoma and Sentinel Node Metastasis Who Have Undergone Sentinel Lymphadenectomy
  • The Utility of FDG-PET for Radiation Treatment in NSCLC
  • A Multicentre Clinical Study of the Sonablate®450 for the TreAtment of Locally Recurrent Prostate Cancer With HIFU (STAR Trial)
  • Quality of Life in Neoadjuvant Versus Adjuvant Therapy of Esophageal Cancer Treatment Trial
  • Thymidylate Synthase Polymorphisms as a Predictor of Toxicity to Capecitabine Chemotherapy in Colon Cancer Treatment
  • An Imaging Pilot Study of 18F-fluoro-3'-Deoxy-3'-L-fluorothymidine (18F-FLT) in Patients With Locally Advanced or Metastatic Pancreatic Cancer Who Will be Treated With Gemcitabine
  • A Phase II Study to Assess Acute Toxicity and Quality of Life of Patients With Carcinoma of the Anal Canal Receiving Chemotherapy and Radiation Using Helical Tomotherapy
  • A Radiopharmacokinetic and Radiodosimetric Phase I Imaging Study of 18F-FAZA
  • A Study to Determine the Value of 18F-FAZA PET Imaging in Patients With Breast Cancer
  • The Effects of Exercise Training on the Health-related Fitness of Colon Cancer Survivors
  • Parent-Delivered Massage in Paediatric Cancer
  • Pilot Study of 18F-FAZA in Assessing Early Functional Response in Patients With Inoperable Non Small Cell Lung Cancer Undergoing Radiation Therapy or Chemo-radiotherapy
  • Continuation Study of Lapatinib Monotherapy or Lapatinib in Combination With Other Anti-cancer Agents
  • Reconstruction Following Pancreaticoduodenectomy: A Randomized Clinical Trial of Pancreaticojejunostomy vs Pancreaticogastomy
  • Hypofractionated Accelerated Post-Operative Radiation Therapy For Prostate Cancer
  • Safety, Tolerability and Systemic Absorption of Menadione Topical Lotion for Epidermal-Growth-Factor-Receptor (EGFR) Inhibitor-Associated Rash
  • Phase II Study of Neoadjuvant Taxotere, Cisplatin, and 5-Fluorouracil in Patients With Gastric or Gastroesophageal Junction Adenocarcinoma
  • A comprehensive study of QOL and fatigue in patients with AML (AML QOL Fatigue)
  • Cisplatin, Etoposide, and Two Different Schedules of Radiation Therapy in Treating Patients With Limited Stage Small Cell Lung Cancer
  • A Study to Assess the effect of IMN 1207 vs Casein on survival, weight loss and quality of life in non-small cell lung cancer patients during or following chemotherapy, RT or surgery
  • Concurrent Once-daily Versus twice-daily Radiation Therapy
  • Stereotactic Body Radiation Therapy in Treating Patients With Stage I or Stage II Non-Small Cell Lung Cancer That Can Be Removed By Surgery
  • High-Dose-Rate Brachytherapy
  • Automating Breast Radiation Therapy (RT)
  • Randomized Phase III Trial Of Doxorubicin/Cisplatin/Paclitaxel And G-CSF Versus Carboplatin/Paclitaxel In Patients With Stage III & IV Or Recurrent Endometrial Cancer
  • Maintenance Therapy in Acute Myeloid Leukemia (AML) Patients
  • Study Evaluating the Tolerance and Biological Activity of Oral Clioquinol in Patients With Relapsed or Refractory Hematological Malignancy
  • Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Liver Cancer
  • Combination Chemotherapy and Surgery in Treating Young Patients With Wilms Tumour
  • One-stage Breast Reconstruction Using Dermal Matrix/Implant Versus Two-stage Expander/Implant Procedure
  • A Prospective Study of Acute Cardiovascular Effects of First-line Sunitinib in Metastatic Renal Cell Carcinoma Patients (Sunitinib Prospective Cardiovascular Effect)
  • Stereotactic Radiosurgery With Sunitinib for Brain Metastases
  • Collecting and Storing Biological Samples From Patients With Ewing Sarcoma
  • Biomarkers in Tumour Tissue Samples From Patients With Newly Diagnosed Neuroblastoma or Ganglioneuroblastoma
  • Collecting and Storing Tissue, Blood, and Bone Marrow Samples From Patients With Rhabdomyosarcoma or Other Soft Tissue Sarcoma
  • Collecting and Storing Tissue Samples From Patients With Rare or Cutaneous Non-Hodgkin Lymphoma
  • Multidisciplinary Approach to Novel Therapies in Cardiology Oncology Research
  • Collecting and Storing Malignant, Borderline Malignant Neoplasms, and Related Samples From Young Patients With Cancer
  • Study of Kidney Tumours in Young Patients
  • Collecting and Storing Samples of Blood and Tumour Tissue From Patients With Osteosarcoma
  • Collecting and Storing Blood and Brain Tumour Tissue Samples From Children With Brain Tumours
  • A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy
  • Radiation Therapy With or Without Temozolomide in Treating Patients With Anaplastic Glioma
  • Safety and Efficacy of Iron Reduction by Phlebotomy
  • Comparing Combination Chemotherapy Regimens in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer
  • The Timing of SU11248 Treatment in Patients With Metastatic Renal Cell Carcinoma
  • CLL11: A Study of Obinutuzumab (RO5072759 [GA101]) With Chlorambucil in Patients With Previously Untreated Chronic Lymphocytic Leukemia (Stage 1a)
  • Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
  • Study to Identify Mechanisms of Resistance to Standard Therapy in Patients With Metastatic Colorectal Cancer
  • Non-invasive Prediction of Microvascular Invasion in Hepatocellular Carcinoma by Blood-Oxygen-Level Dependent Magnetic Resonance Imaging (BOLD MRI)
  • Sentinel Node Biopsy Following NeoAdjuvant Chemotherapy in Biopsy Proven Node Positive Breast Cancer
  • A Study of MetMAb Administered to Patients With Advanced Non-Small Cell Lung Cancer, in Combination With Tarceva (Erlotinib)
  • Prostate cancer study of CRT + Upfront ADT vs. PHPC + Salvage ADT
  • Efficacy of Ultrasound Contrast Agent to Assess Renal Masses
  • Duration of Suppression of Bone Turnover Following Treatment With Zoledronic Acid in Men With Metastatic Castration Resistant Prostate Cancer
  • Laparoscopic Approach to Cervical Cancer
  • Assessment of Cardiotoxicity by Cardiac Magnetic Resonance (CMR) in Breast Cancer Patients Receiving Trastuzumab
  • Irinotecan pharmacogenomics
  • Myelodysplastic Syndromes (MDS) Event Free Survival With Iron Chelation Therapy Study
  • Radiation Therapy With or Without Cetuximab in Treating Patients Who Have Undergone Surgery for Locally Advanced Head and Neck Cancer
  • CTC Pros
  • MRI Targeted Focal Laser Thermal Therapy of Prostate Cancer
  • Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer
  • Randomized Anastrozole Exercise Trial (RAE)
  • Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Peripheral T-Cell Non-Hodgkin's Lymphoma
  • Tailoring Treatment for B Cell Non-hodgkin's Lymphoma Based on PET Scan Results Mid Treatment
  • Safety Study of Oral MGCD265 Administered Without Interruption to Subjects With Advanced Malignancies
  • Radiation Doses and Fractionation Schedules in Non-low Risk Ductal Carcinoma In Situ (DCIS) of the Breast
  • MET/VEGFR2 Inhibitor GSK1363089 and Erlotinib Hydrochloride or Erlotinib Hydrochloride Alone in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer That Has Not Responded to Previous Chemotherapy
  • Image-Guided Radiosurgery or Stereotactic Body Radiation Therapy in Treating Patients With Localized Spine Metastasis
  • A Registry Study of Permanent Breast Seed Implant
  • A Study of MK1775 in Combination With Topotecan/Cisplatin in Patients With Cervical Cancer (1775-008)
  • TEM Timing
  • 18F-fluorodeoxyglucose (18F-FDG) Positron Emission Tomography in Oncology
  • Study of Vorinostat (MK0683), an HDAC Inhibitor, in Combination With Bortezomib in Patients With Relapsed or Refractory Multiple Myeloma (0683-095)
  • A Randomized Phase III Study of Standard Treatment +/- Enoxaparin in Small Cell Lung Cancer
  • Open-Label Study of Lenalidomide in Combination With Oral Dexamethasone in the Treatment of Previously Untreated, Symptomatic Patients With Chronic Lymphocytic Leukemia
  • Collecting and Storing Samples of Bone Marrow and Blood From Patients With Relapsed Acute Lymphoblastic Leukemia or Non-Hodgkin Lymphoma
  • Combination Chemotherapy, Autologous Stem Cell Transplant, and/or Radiation Therapy in Treating Young Patients With Extraocular Retinoblastoma
  • Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)
  • Involved Field Radiation Therapy for Non-gastric Marginal Zone Lymphoma
  • Collecting and Storing Biological Samples From Young Patients With Hodgkin's Lymphoma
  • Collecting and Storing Tissue From Young Patients With Cancer
  • A Phase III Randomized Trial of Metformin vs Placebo in Early Stage Breast Cancer
  • Positron Emission Tomography/Computerized Tomography (PET/CT) Guided Fulvestrant Therapy for Patients With Recurrent or Metastatic Breast Cancer
  • Study of Vidaza Versus Conventional Care Regimens for the Treatment of Acute Myeloid Leukemia (AML)
  • Continued HER2 Suppression With Lapatinib Plus Trastuzumab Versus Trastuzumab Alone
  • Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed By the Same Chemotherapy Regimen With or Without Radiation Therapy and Capecitabine or Fluorouracil in Treating Patients With Pancreatic Cancer That Has Been Removed By Surgery
  • Study of a Tiotropium Inhaler For Shortness of Breath in Advanced Non-Small Cell Lung Cancer
  • Study of Adding AMG 479 to First Line Chemotherapy in Patients With Optimally Debulked Epithelial Ovarian Cancer
  • LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
  • Safety and Efficacy Study of Nilotinib Combined With Mitoxantrone, Etoposide, and High-dose Cytarabine Induction Chemotherapy Followed by Consolidation for Patients With C-kit Positive Acute Myeloid Leukemia
  • A Study of R04929097 in Combination With Gemcitabine in Patients With Advanced Solid Tumours
  • Early Diagnosis of Lung Cancer and Mesothelioma in Prior Asbestos Workers
  • Study to Determine the Maximum Tolerated Dose and Evaluate the Efficacy and Safety of CEP-18770 in Patients With Relapsed Multiple Myeloma Refractory to the Most Recent Therapy
  • N2007-02:Bevacizumab,Cyclophosphamide,& Zoledronic Acid in Patients W/ Recurrent or Refractory High-Risk Neuroblastoma
  • The Triumph Study
  • A Study to Demonstrate the Safety and Preliminary Efficacy of 18F-FLT in Patients With Solid Tumours or Lymphoma
  • Ofatumumab and Bendamustine Combination Therapy Compared With Bendamustine Monotherapy in Indolent B-cell Non-Hodgkin's Lymphoma (NHL) Unresponsive to Rituximab or a Rituximab-Containing Regimen
  • Maintenance Chemotherapy or Observation Following Induction Chemotherapy and Radiation Therapy in Treating Younger Patients With Newly Diagnosed Ependymoma
  • Oncology Treatment Decisions
  • A Study of Perioperative Chemotherapy Plus Panitumumab in Patients With Colorectal Cancer Liver Metastases
  • A Study to Investigate the Efficacy and Safety of Bendamustine Compared With Bendamustine+RO5072759 (GA101) in Patients With Rituximab-Refractory, Indolent Non-Hodgkin's Lymphoma (GADOLIN)
  • First Line Study of Irinotecan, Capecitabine and Oxaliplatin in Metastatic Gastric or Gastroesophageal Cancer.
  • Immediate Surgery or Surgery After Sunitinib Malate in Treating Patients With Metastatic Kidney Cancer
  • Single Agent Ofatumumab Vs. Single Agent Rituximab in Follicular Lymphoma Relapsed After Rituximab-Containing Therapy
  • Radiation Therapy in Treating Patients With Extensive Stage Small Cell Lung Cancer
  • Risk-Adapted Chemotherapy in Younger Patients With Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia
  • Lenalidomide & High Dose Dexamethasone for Untreated Multiple Myeloma Renal Failure Patients
  • Comparison of Primovist-enhanced MRI, Diffusion Weighted MRI and Multidetector CT of Colorectal Liver Metastases
  • A Phase II Study of Oral Panobinostat (LBH589) and Rituximab to Treat Diffuse Large B Cell Lymphoma (DLBCL)
  • Lifestyle Intervention for Polycystic Ovary Syndrome: Pulse-Based Diet and Exercise
  • Focal MR-Guided Focused Ultrasound Treatment of Localized Low-Risk Prostate Cancer: Feasibility Study
  • Cediranib Maleate With or Without Lenalidomide in Treating Patients With Thyroid Cancer
  • Low-Dose Tamoxifen Citrate in Reducing Breast Cancer Risk in Radiation-Induced Cancer Survivors
  • Radiation Therapy or Radiation Therapy and Temozolomide or Temozolomide Alone in Treating Patients With Newly Diagnosed Anaplastic Glioma
  • Study of Intratumoural Hypoxia Using Pre-operative Administration of Pimonidazole
  • Study to Identify Molecular Mechanisms of Clinical Resistance to Chemotherapy in Triple Negative Breast Cancer Patients
  • Optimum Timing for Surgery After Pre-operative Radiation Therapy 6 vs 12 Weeks
  • A Study on the Timing of FOLFOX for Patients With Operable, Node Positive Rectal Cancer
  • Living With Hope Program for Rural Women Caregivers
  • A Randomized Clinical Trial of Megestrol Acetate as an Appetite Stimulant in Malnourished Children With Cancer
  • Osteonecrosis in Children With Acute Lymphoblastic Leukemia
  • Phase I/II Study of Ribavirin Given as Monotherapy in Solid Tumour Cancer Patients
  • A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase CML or With Ph+ Leukemias Resistant or Intolerant to Imatinib
  • Role of Cyberknife Stereotactic Radiation Therapy (SBRT) Followed by Gemcitabine for Patients With Locally Advanced Pancreatic Cancer
  • Capecitabine and Vorinostat in Treating Patients With Recurrent and/or Metastatic Head and Neck Cancer
  • Dexamethasone vs Placebo in the Prophylaxis of Radiation-Induced Pain Flare Following Palliative Radiation Therapy for Bone Metastases
  • A Trial of Standard Chemotherapy With Metformin (vs Placebo) in Women With Metastatic Breast Cancer
  • A Study of AUY922 in Non-small-cell Lung Cancer Patients Who Have Received Previous Two Lines of Chemotherapy.
  • An Investigational Drug, Crizotinib (PF-02341066), Is Being Studied In Tumours, Except Non-Small Cell Lung Cancer, That Are Positive For Anaplastic Lymphoma Kinase (ALK)
  • Adjuvant Androgen Suppression Plus Radiation Therapy for High-Risk Localized Adenocarcinoma Prostate
  • Thoracoscopic Localization of Pulmonary Nodules Using Direct Intracavitary Thoracoscopic Ultrasound
  • A Comparison of Contrast Enhanced Ultrasound (CEUS) and Contrast Enhanced Computed Tomography (CT) or Magnetic Resonance Imaging (MRI) for Characterization of Focal Liver Masses
  • Phase II Randomized Trial Evaluating Neoadjuvant Therapy With Neratinib and/or Trastuzumab Followed by Postoperative Trastuzumab in Women With Locally Advanced HER2-positive Breast Cancer
  • Gynaecological Follow-up of a Subset of HPV-015 (NCT00294047) Study Subjects
  • Observing Patients With Palliative Asymptomatic Centrally Located Advanced Non-small Cell Lung Carcinoma (NSCLC)
  • Stereotactic Body Radiation Therapy (SBRT) for Spinal/Para-Spinal Metastases (Spine SBRT)
  • Surgery Versus Radiosurgery for the Treatment of Single Brain Metastases
  • Temozolomide and Irinotecan Hydrochloride With or Without Bevacizumab in Treating Young Patients With Recurrent or Refractory Medulloblastoma or CNS Primitive Neuroectodermal Tumours
  • Radiation Therapy and Cisplatin in Treating Patients With Stage I Bladder Cancer
  • Polyethylene Glycol (PEG) Versus Sennosides Study in Opioid-Induced Constipation in Cancer Patients
  • Sorafenib Tosylate With or Without Doxorubicin Hydrochloride in Treating Patients With Locally Advanced or Metastatic Liver Cancer
  • Study of Efficacy and Safety in Polycythemia Vera Subjects Who Are Resistant to or Intolerant of Hydroxyurea: JAK Inhibitor INC424 (INCB018424) Tablets Versus Best Available Care: The RESPONSE Trial
  • Risk-Based Classification System of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
  • Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery
  • Efficacy and Safety Study of Leukocyte Interleukin,Injection (LI) to Treat Cancer of the Oral Cavity
  • Radiation Therapy With or Without Chemotherapy in Treating Patients With High-Risk Malignant Salivary Gland Tumours That Have Been Removed By Surgery
  • CT-validation of Ultrasound Based Planning for High Dose Rate (HDR) Prostate Brachytherapy Using Vitesse
  • The Natural History of Small Renal Masses
  • A Pharmacokinetic Study of Trabectedin in Patients With Advanced Malignancies and Hepatic Dysfunction
  • Safety Study Evaluating Intravenous Infusions of Tigecycline to Treat Acute Myeloid Leukemia
  • Aprepitant as Antiemetic Prophylaxis in Patients With Acute Myeloid Leukemia Undergoing Induction Chemotherapy
  • A Trial to Evaluate the Improvement in Lung Cancer Patients Receiving Radiation With or Without Brachytherapy
  • Facilitating Physical Activity Behaviour and Health Outcomes in Breast Cancer Patients Receiving Chemotherapy
  • Study of Oral IXAZOMIB in Combination With Melphalan and Prednisone in Patients With Newly Diagnosed Multiple Myeloma
  • Conventional Ultrasound for Imaging of Prostate Cancer Extent and Response in Human Cancer Patients
  • Suppression of Bone Turnover Following Treatment With Zoledronic Acid in Patients With Metastatic Breast Cancer: Duration of Effect
  • Safety Evaluation of Dexmedetomidine for EBUS-TBNA
  • Effectiveness of Doxycycline for Treating Pleural Effusions Related to Cancer in an Outpatient Population
  • Assessing DNA Changes in High Risk Prostate Cancer to Determine Prognosis
  • Seed Movement in Prostate Brachytherapy Implants: Clinical Measurement and Dosimetric Consequences
  • A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
  • A Phase II Study of Sunitinib or Temsirolimus in Patients With Advanced Rare Tumours
  • An Open-Label, Multi-Centre, Expanded Access Program With Eribulin for the Treatment of Advanced Breast Cancer Refractory
  • A Study of MK-1775 in Combination With Paclitaxel and Carboplatin Versus Paclitaxel and Carboplatin Alone for Participants With Platinum-Sensitive Ovarian Tumours With the P53 Gene Mutation (MK-1775-004)
  • The ODYSSEY Study
  • A Study of LCL161 in Combination With Weekly Paclitaxel in Adult Patients With Advanced Solid Tumours
  • Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy
  • Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer
  • Femoral Bone Metastases
  • A Study to Measure Needle Bending and Changes in Prostate Shape During a Prostate Seed Implant
  • Acupressure in Controlling Nausea in Young Patients Receiving Highly Emetogenic Chemotherapy
  • LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy
  • Caspofungin Acetate or Fluconazole in Preventing Invasive Fungal Infections in Patients With Acute Myeloid Leukemia Who Are Undergoing Chemotherapy
  • Stereotactic Ablative Radiation Therapy for Comprehensive Treatment of Oligometastatic Tumours (SABR-COMET)
  • The EPIC Study
  • Pilot Study of Partial Breast Irradiation Utilizing Permanent Breast Seed Implant to Treat Breast Cancer
  • Y90 Ibritumomab Tiuxetan Post R-CHOP Chemotherapy for Advanced Stage Follicular Lymphoma
  • OPTIM DASATINIB
  • Extended Peri-operative Tinzaparin to Improve Disease-free Survival in Patients With Resectable Colorectal Cancer
  • A Phase 3, Multicentre, Randomized, Open-Label Study to Compare the Efficacy and Safety of Pomalidomide in Combination With Low-Dose Dexamethasone Versus High-Dose Dexamethasone in Patients With Refractory Multiple Myeloma or Relapsed and Refractory Multiple Myeloma and Companion Study
  • Biomarker Directed Adjuvant Chemotherapy for Resected Pancreas Cancer
  • Study of Nivolumab (BMS-936558) in Combination With Gemcitabine/Cisplatin, Pemetrexed/Cisplatin, Carboplatin/Paclitaxel, Bevacizumab Maintenance, Erlotinib, Ipilimumab or as Monotherapy in Subjects With Stage IIIB/IV Non-small Cell Lung Cancer (NSCLC) (CheckMate 012)
  • Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL
  • SPY-1
  • The Young Women's Breast Cancer Study
  • A phase I clinical study of BBI608 in adult patient with advanced solid tumours.
  • Study of GDC-0941 or GDC-0980 With Fulvestrant Versus Fulvestrant in Advanced or Metastatic Breast Cancer in Patients Resistant to Aromatase Inhibitor Therapy
  • Lux-Breast 3; Afatinib Alone or in Combination With Vinorelbine in Patients With Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer Suffering From Brain Metastases
  • A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumour or Hematologic Malignancy (V212-011)
  • Frameless Stereotactic Radiosurgery for Brain Metastases
  • Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
  • Efficacy of Optically-guided Surgery in the Management of Early-staged Oral Cancer - COOLS TRIAL
  • A Study of BI 853520 in Patients With Various Types of Advanced or Metastatic Cancer
  • Pilot Study Using a PET Gamma Probe to Evaluate Lymph Nodes in Endometrial Cancer
  • Clinical Study Of PI3K/mTOR Inhibitors In Combination With An Oral MEK Inhibitor Or Irinotecan In Patients With Advanced Cancer
  • Study of ABT-888 in Combination With Bortezomib and Dexamethasone in Patients With Relapsed Refractory Myeloma
  • Study to Evaluate the Safety and Efficacy of Pomalidomide Monotherapy in Subjects With Refractory or Relapsed Refractory Multiple Myeloma
  • Active Surveillance Magnetic Resonance Imaging Study
  • Study of Efficacy and Safety of Sunitinib Given on an Individualized Schedule
  • Feasibility of Evaluating Gene Alteration Analysis Using Samples Obtained by EBUS-TBNA in Patients With Lung Cancer
  • Stereotactic Body Radiation Therapy (RT) for Non-Small Cell Lung Cancer
  • ExAblate (Magnetic Resonance-guided Focused Ultrasound Surgery) Treatment of Brain Tumours
  • Bone biopsy study
  • Robotic Compared to Fixed Gantry Radiosurgery for Brain Metastases
  • A Study to Evaluate the Safety and Immunogenicity of Inactivated Varicella-Zoster Virus (VZV) Vaccine in Adults With HM Receiving Treatment With Anti-CD20 Monoclonal Antibodies (V212-013)
  • Managing Cancer and Living Meaningfully (CALM): A Study to Evaluate the Effectiveness of a Psychological Intervention for Cancer Patients
  • Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer
  • Breast Cancer and Exercise Trial in Alberta
  • Early Surgery or Standard Palliative Therapy in Treating Patients With Stage IV Breast Cancer
  • Hypofractionated, Dose Escalation Radiation Therapy for High Risk Adenocarcinoma of the Prostate
  • A Study of Brentuximab Vedotin in Relapsed or Refractory Non-Hodgkin Lymphoma
  • Subcutaneous Lidocaine For Cancer-Related Pain
  • Renal Hypothermia During Partial Nephrectomy
  • Prostate Cancer Localization With a Multiparametric Magnetic Resonance (MR) Approach
  • A Phase I Dose Escalation Study of BKM120 With Radiation Therapy and Temozolomide in Patients With Newly Diagnosed Glioblastoma
  • Integrated Molecular Profiling in Advanced Cancers Trial
  • An Open-Label Phase 2 Study of Ofatumumab (Arzerra) in Combination With Oral GSK2110183 in the Treatment of Relapsed and Refractory Chronic Lymphocytic Leukemia (CLL)
  • Long Term Outcomes of Breast Intensity-Modulated Radiation Therapy
  • Levofloxacin in Preventing Infection in Young Patients With Acute Leukemia Receiving Chemotherapy or Undergoing Stem Cell Transplantation
  • Comparison of Dexmedetomidine and Propofol-Remifentanil Conscious Sedation for Awake Craniotomy for Tumour Surgery
  • Radiosensitization of AVASTIN® (Bevacizumab) With Stereotactic Body Radiation Therapy for Colorectal Liver Metastasis
  • Prostate Hypoxia FAZA
  • Sentinel Node Biopsy in Endometrial Cancer
  • Cervix Hypoxia FAZA
  • Stereotactic Radiosurgery or Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases That Have Been Removed By Surgery
  • Neoadjuvant Chemotherapy vs. Chemoradiation for Resectable Esophageal Cancer
  • Study of MK-8242 Alone and in Combination With Cytarabine in Participants With Acute Myelogenous Leukemia (P07649)
  • A Study Using 18F-FAZA and PET Scans to Study Hypoxia in Pancreatic Cancer
  • A Phase II Randomized Trial for Early-stage Squamous Cell Carcinoma of the Oropharynx: Radiation Therapy vs Trans-oral Robotic Surgery (ORATOR)
  • Laboratory Testing for Tie-2 Expressing Monocytes (TEMs) in Blood
  • A Three-part Study of Eltrombopag in Thrombocytopenic Subjects With Myelodysplastic Syndromes or Acute Myeloid Leukemia
  • A Study of MM-121 With Paclitaxel in Platinum Resistant/ Refractory Advanced Ovarian Cancers
  • Safety and Tolerability Study of SOR-C13 in Subjects With Advanced Cancers Commonly Known to Express the TRPV6 Channel
  • Self-Management Intervention for Breathlessness in Lung Cancer
  • Focal Salvage HDR Brachytherapy for the Treatment of Prostate Cancer
  • A Rollover Protocol for Subjects Previously Treated With AGS-003
  • Phase III Study of BKM120/Placebo With Fulvestrant in Postmenopausal Patients With Hormone Receptor Positive HER2-negative Locally Advanced or Metastatic Breast Cancer Refractory to Aromatase Inhibitor
  • Radiation Therapy With or Without Cisplatin in Treating Patients With Recurrent Endometrial Cancer
  • Outpatient Platelet Transfusions in Myelodysplastic Syndromes and Leukemia: The OPTIMAL Pilot
  • The Effect of Non-Steroidal Anti-Inflammatory Drug Naproxen on Pleural Effusion Formation After Lung Resection
  • Natural History of Brain Function, Quality of Life, and Seizure Control in Patients With Brain Tumour Who Have Undergone Surgery
  • Conventional Versus Hypofractionated Radiation in High Risk Prostate Patients
  • Safety Study of the Selective Inhibitor of Nuclear Export (SINE) KPT-330 in Patients With Advanced or Metastatic Solid Tumour Cancer
  • Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
  • Investigation Into the Differentiation of Tumour and Healthy Brain Tissue Using Multi-exponential T2 Components
  • Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma
  • Reolysin in Combination With FOLFOX6 and Bevacizumab or FOLFOX6 and Bevacizumab Alone in Metastatic Colorectal Cancer
  • P13Kinase Inhibitor BKM120 in Combination With Panitumumab in Patients With Metastatic or Advanced RAS-Wild Type Colorectal Cancer.
  • Regorafenib in Subjects With Metastatic Colorectal Cancer (CRC) Who Have Progressed After Standard Therapy
  • Cisplatin and Radiation Therapy With or Without Carboplatin and Paclitaxel in Patients With Locally Advanced Cervical Cancer
  • Study of Palifosfamide-tris in Combination With Carboplatin and Etoposide in Chemotherapy Naïve Patients With Extensive-Stage Small Cell Lung Cancer (The MATISSE Study)
  • Prospective Liver Tumour (ProLiT) Database
  • Polarized Reflectance Spectroscopy for Oral Lesions
  • A Study of Trastuzumab Emtansine Versus Taxane in Patients With Advanced Gastric Cancer
  • Shrinking Target Adaptive Radiation Therapy for Locally Advanced Non-Small Cell Lung Cancer
  • Sorafenib in Treating Young Patients With Relapsed or Refractory Solid Tumours or Leukemia
  • Study in Head and Neck Cancer
  • A Study in Head and Neck Cancer
  • High Dose Rate Prostate Brachytherapy: Dose Escalation to Dominant Intra-prostatic Nodule
  • Pro-coagulant Markers and Anticoagulant Failure in Cancer Patients at Risk for Recurrence of Venous Thromboembolism
  • A Study of LY2784544 in Participants With Myeloproliferative Neoplasms
  • A Study Comparing Chemotherapy Dosing Based on Either Standard Body Surface Area or Lean Body Mass in Patients With Advanced Lung Cancer
  • A Study Combining mFOLFOX6 With Tivozanib or Bevacizumab in Patients With Metastatic Colorectal Cancer as First Line Therapy
  • Quality of Life and Dysphagia Following Palliative Stenting in Esophageal Cancer
  • A Study of Pertuzumab in Combination With Herceptin (Trastuzumab) and A Taxane in First-Line Treatment in Patients With HER2-Positive Advanced Breast Cancer (PERUSE)
  • Cervical Video Assisted Thoracoscopic Surgery (C-VATS)
  • Predicting Malignancy Using Endoluminal Ultrasound Characteristics in Mediastinal Lymph Nodes
  • Cancer, fertility and motherhood
  • Brentuximab Vedotin and Bendamustine for the Treatment of Hodgkin Lymphoma and Anaplastic Large Cell Lymphoma (ALCL)
  • A Randomized Controlled Trial of an Online Support Group for Sexual Distress Due to Gynecologic Cancer
  • Nausea and Vomiting in Children Receiving Chemotherapeautic Monotherapy
  • Aromatase Inhibitor Host Factors Study
  • A Study of Subcutaneous Versus Intravenous MabThera/Rituxan (Rituximab) in Combination With CHOP Chemotherapy in Patients With Previously Untreated CD20-Positive Diffuse Large B-Cell Lymphoma
  • A Trial Comparing Efficacy and Safety of Voriconazole Administered With Therapeutic Drug Monitoring vs. Standard Dosing
  • A Phase Ib/II Study of LGX818 in Combination With MEK162 in Adult Patients With BRAF Dependent Advanced Solid Tumours
  • Study of the Predictive Marker FLT in Patients Suffering From AML
  • The Value of Botox-A for Management of Low Anterior Resection Syndrome
  • STEVIE: A Study of Vismodegib in Patients With Locally Advanced or Metastatic Basal Cell Carcinoma
  • Continuation Study of the Oral AKT Inhibitor GSK2110183
  • A Rollover Study to Provide Continued Treatment With GSK2118436 to Subjects With BRAF Mutation-Positive Tumours
  • Molecular Mechanisms of Dutasteride and Dietary Interventions to Prevent Prostate Cancer and Reduce Its Progression
  • Vitamin D Loading Dose in Advanced Lung Cancer
  • Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia
  • Multimodal Prehabilitation for Colorectal Surgery
  • Study Evaluating the Safety and Efficacy of Carboplatin/Paclitaxel and Carboplatin/Paclitaxel/Bevacizumab With and Without GDC-0941 in Patients With Previously Untreated Advanced or Recurrent Non-small Cell Lung Cancer
  • A Dose-finding Study of a Combination of Imatinib and BKM120 in the Treatment of 3rd Line GIST Patients
  • BRIM8: A Study of Vemurafenib Adjuvant Therapy in Patients With Resected Cutaneous BRAF Mutant Melanoma
  • Study of Positron Emission Tomography and Computed Tomography in Guiding Radiation Therapy in Patients With Stage III Non-Small Cell Lung Cancer
  • A Study of Reolysin For Patients With Advanced/Metastatic Breast Cancer
  • A Trial of ASP7487 (OSI-906) in Combination With Bortezomib for the Treatment of Relapsed Multiple Myeloma
  • Radical Versus Simple Hysterectomy and Pelvic Node Dissection in Patients With Early Stage Cervical Cancer
  • A Study of Dalotuzumab + MK-2206 and Dalotuzumab + MK-0752 Combination Therapies in Participants With Advanced Cancer (MK-0646-027)
  • Combination Chemotherapy With or Without Rituximab in Treating Younger Patients With Stage III-IV Non-Hodgkin Lymphoma or B-Cell Acute Leukemia
  • A Study of Avastin (Bevacizumab) in Combination With Temolozomide (TMZ) and Radiation Therapy in Paediatric and Adolescent Patients With High-Grade Glioma
  • Ipilimumab in Treating Patients With Metastatic or Recurrent Human Papilloma Virus-Related Cervical Cancer
  • A Multi-National, Prospective, Observational Study in Patients With Unresectable or Metastatic Melanoma
  • A Combination Study of Kadcyla (Trastuzumab Emtansine) and Capecitabine in Patients With HER2-Positive Metastatic Breast Cancer and Patients With HER2-Positive Locally Advanced / Metastatic Gastric Cancer
  • Hormone Therapy, Radiation Therapy, and Steroid 17alpha-monooxygenase TAK-700 in Treating Patients With High-Risk Prostate Cancer
  • Provide Expanded Access to MDV3100 and Monitor Its Safety in Patients With Progressive Castration-Resistant Prostate Cancer Previously Treated With Docetaxel-Based Chemotherapy
  • Feasibility Study of Genomic Profiling Methods and Timing in Tumour Samples
  • Study of INC280 in Patients With c-MET Dependent Advanced Solid Tumours
  • Reolysin Combined With Docetaxel and Prednisone or Docetaxel and Prednisone Alone in Metastatic Castration Resistant Prostate Cancer
  • Early Detection of Lung Cancer and Mesothelioma in Workers Exposed to Asbestos
  • A Phase 3 Study Comparing Oral IXAZOMIB Plus Lenalidomide and Dexamethasone Versus Placebo Plus Lenalidomide and Dexamethasone in Adult Patients With Relapsed and/or Refractory Multiple Myeloma
  • Firmagon (Degarelix) Intermittent Therapy
  • Chemotherapy Followed by Radiation Therapy in Treating Younger Patients With Newly Diagnosed Localized Central Nervous System Germ Cell Tumours
  • ED-TBI Followed By Allogeneic Stem Cell Transplantation For The Treatment Of Refractory AML And Advanced MDS
  • First-Line Treatment for Locally Advanced or Metastatic Mesenchymal Epithelial Transition Factor (MET) - Positive Gastric, Lower Esophageal, or Gastroesophageal Junction (GEJ) Adenocarcinoma
  • Reolysin in Patients With Previously Treated Advanced or Metastatic, Non Small Cell Lung Cancer Receiving Standard Salvage Therapy
  • Trial Comparing Adjuvant Chemotherapy With Gemcitabine Versus mFolfirinox to Treat Resected Pancreatic Adenocarcinoma
  • A Study of Oral CFG920 in Patients With Castration Resistant Prostate Cancer
  • Thermal Ablation in Larger Liver and Kidney Tumours
  • Pantoprazole and Docetaxel for Men With Metastatic Castration-Resistant Prostate Cancer
  • Urine Metabolomics and Colorectal Cancer Screening
  • Optical Coherence Tomography for Monitoring Late Oral Radiation Toxicity After Radiation Therapy of Head and Neck Cancer Patients
  • Novel Controlled Hypo-Perfusion Technique in Partial Nephrectomy
  • A Phase I/Ib Trial for the Evaluation of SAR260301 in Monotherapy or in Combination With Vemurafenib in Patients With Various Advanced Cancer
  • Study of LGX818 and Cetuximab or LGX818, BYL719, and Cetuximab in BRAF Mutant Metastatic Colorectal Cancer
  • Study of ENMD-2076 in Patients With Advanced/Metastatic Soft Tissue Sarcoma
  • Study of Dacomitinib With Radiation Therapy With and Without Cisplatin in Patients With Squamous Cell Carcinoma of the Head and Neck
  • A Phase Ib/II Study of BYL719 and Cetuximab in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
  • OGX-427 in Metastatic Castrate-Resistant Prostate Cancer With Prostate-Specific Antigen Progression While Receiving Abiraterone
  • Multiparametric MRI for Prostate Cancer Localization and Characterization: New Methods
  • Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)
  • A Study of Sunitinib In Young Patients With Advanced Gastrointestinal Stromal Tumour
  • Tranexamic Acid Versus Placebo for Blood to Reduce Perioperative Bleeding Post-liver Resection
  • A Study to See if hENT1 Testing on Tumour Tissue Can Predict Response to Treatment With Gemcitabine Chemotherapy and if a Different Chemotherapy Called FOLFOX is Better Than Gemcitabine in Metastatic Pancreas Cancer
  • Multidisciplinary Team IntervenTion in CArdio-ONcology (TITAN Study)
  • Exercise in Pediatric Autologous Stem Cell Transplant Patients
  • Comparing Robotics and Laparoscopy With Laparotomy/Open Surgery for Endometrial Cancer
  • The Study Evaluating Efficacy And Tolerability Of Veliparib in Combination With Temozolomide or In Combination With Carboplatin and Paclitaxel Versus Placebo in Subjects With BRCA1 and BRCA2 Mutation and Metastatic Breast Cancer
  • A Study of the BRAF Inhibitor Dabrafenib in Combination With the MEK Inhibitor Trametinib in the Adjuvant Treatment of High-risk BRAF V600 Mutation-positive Melanoma After Surgical Resection.
  • A Study of Patient Preference With Subcutaneous Versus Intravenous MabThera/Rituxan (Rituximab) in Patients With CD20+ Diffuse Large B-Cell Lymphoma or CD20+ Follicular Non-Hodgkin's Lymphoma Grades 1, 2 or 3a
  • Exercise and Nutrition for Head and Neck Cancer Patients
  • Efficacy and Safety Study of NeuVax™ (Nelipepimut-S or E75) Vaccine to Prevent Breast Cancer Recurrence
  • Early Diagnosis of Pulmonary Nodules
  • RTOG 0920: A Study of Postoperative Radiation Therapy (IMRT) +/- Cetuximab for Locally-advanced Resected Head and Neck Cancer
  • A Study of BBI608 in Adult Patients With Advanced Malignancies
  • Efficacy Evaluation of TheraSphere in Patients With Inoperable Liver Cancer
  • Open-label, Uncontrolled Phase II Trial of Intravenous PI3K Inhibitor BAY80-6946 in Patients With Relapsed, Indolent or Aggressive Non-Hodgkin's Lymphomas
  • Comparison of Surgical Approach to Endoscopic Pituitary Adenoma Resection
  • Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery
  • A Study of BBI503 in Adult Patients With Advanced Solid Tumours
  • A Study of Trastuzumab Emtansine Versus Trastuzumab as Adjuvant Therapy in Patients With HER2-Positive Breast Cancer Who Have Residual Tumour in the Breast or Axillary Lymph Nodes Following Preoperative Therapy (KATHERINE)
  • A Study of Genetic Based Chemotherapy Dosing for Breast Cancer Patients
  • Evaluation of Endobronchial Ultrasound (EBUS) for Staging Lung Cancer
  • Tumour TARGET Prostate Cancer
  • Dandelion Root Extract in Patients with Refractory Hematologic Malignancies
  • Early Palliative Care for Patients with Advanced Epithelial Ovarian Cancer
  • Stereotactic Radiation Therapy (SBRT) of Lung Metastasis
  • Imaging With 111 Indium (111In)-Pertuzumab (PmAb) to Predict Response to Trastuzumab (TmAb) in Human Epidermal Growth Factor-2 (HER2) Positive Metastatic Breast Cancer (MBC)
  • A Study of Perjeta (Pertuzumab) in Combination With Herceptin (Trastuzumab) and Chemotherapy in Patients With HER2-Positive Metastatic Gastroesophageal Junction or Gastric Cancer
  • Utilization of Genomic Information to Augment Chemotherapy Decision-making for People With Incurable Malignancies
  • A Prospective Cohort Study Evaluating Risk of Local Recurrence Following Breast Conserving Surgery and Endocrine Therapy in Low Risk Luminal A Breast Cancer
  • NEXT (Nutrition and EXercise During Adjuvant Treatment) Study
  • Alisertib (MLN8237) or Investigator&Apos;s Choice in Patients With Relapsed/Refractory Peripheral T-Cell Lymphoma
  • The Prone Breast Radiation Therapy Trial
  • A Study of XL184 (Cabozantinib) in Endometrial Cancer
  • Treatment-free Remission After Achieving Sustained MR4.5 on Nilotinib (ENESTop)
  • Phase III Study of CPX-351 Versus 7+3 in Patients 60-75 Years Old With Untreated High Risk (Secondary) Acute Myeloid Leukemia
  • Prospective Study Using Hybrid PET/MRI to Evaluate Men With Suspected Recurrence Following Treatment for Prostate Cancer
  • Endobronchial Ultrasound-guided Transbronchial Needle Aspiration for Lymph Node Staging in Patients With Non-small Cell Lung Cancer Pursuing Stereotactic Body Radiation Therapy (SBRT)
  • Perspectives of Receiving Open Versus Minimally Invasive Surgery
  • Remote Ischemia Pre-Conditioning in Patients Undergoing Partial Nephrectomy
  • Volasertib in Combination With Low-dose Cytarabine in Patients Aged 65 Years and Above With Previously Untreated Acute Myeloid Leukaemia, Who Are Ineligible for Intensive Remission Induction Therapy (POLO-AML-2)
  • Mismatched Donor Cells to Treat Acute Myeloid Leukemia
  • Safety and Quality of Life Study of Aflibercept in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin-Based Regimen
  • A Phase II Study of Oral LDE225 in Patients With Hedge-Hog (Hh)-Pathway Activated Relapsed Medulloblastoma (MB)
  • Gemcitabine Hydrochloride and Cisplatin With or Without Veliparib or Veliparib Alone in Patients With Locally Advanced or Metastatic Pancreatic Cancer
  • Veliparib and Radiation Therapy in Treating Patients With Advanced Solid Malignancies With Peritoneal Carcinomatosis, Epithelial Ovarian, Fallopian, or Primary Peritoneal Cancer
  • ECHELON-2: A Comparison of Brentuximab Vedotin and CHP With Standard-of-care CHOP in the Treatment of Patients With CD30-positive Mature T-cell Lymphomas
  • A Study of RO5503781 as Single Agent or in Combination With Cytarabine in Patients With Acute Myelogenous Leukemia
  • A Study Of Inotuzumab Ozogamicin Versus Investigator's Choice Of Chemotherapy In Patients With Relapsed Or Refractory Acute Lymphoblastic Leukemia
  • Focal Therapy for Prostate Cancer - A Pilot Study of Focal Low Dose Rate Brachytherapy
  • Combining Doxycycline With Bone-Targeted Therapy in Patients With Metastatic Breast Cancer
  • Studying the Physical Function and Quality of Life Before and After Surgery in Patients With Stage I Cervical Cancer
  • A Study of Abiraterone Acetate Plus Low-Dose Prednisone Plus Androgen Deprivation Therapy (ADT) Versus ADT Alone in Newly Diagnosed Participants With High-Risk, Metastatic Hormone-Naive Prostate Cancer (mHNPC)
  • Study of Selumetinib in Patients With Previously Treated or Untreated Advanced/Metastatic NSCLC
  • Hepatocellular Carcinoma Using Stereotactic Body Radiation Therapy
  • Prostate Delineation: High Quality Volume CT
  • Temperature, Heart and Respiratory Rate Investigation Along With Variability Evaluation and Serum Biomarkers (THRRIVES)
  • The Metformin Active Surveillance Trial (MAST) Study
  • A Phase II Trial of High Dose-Rate Brachytherapy as Monotherapy in Low and Intermediate Risk Prostate Cancer
  • Clinical Trial Testing TH-302 in Combination With Gemcitabine in Previously Untreated Subjects With Metastatic or Locally Advanced Unresectable Pancreatic Adenocarcinoma (MAESTRO)
  • SGI-110 in the Treatment of Advanced Hepatocellular Carcinoma (HCC)
  • Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster (HZ/su) Vaccine in Adults With Solid Tumours Receiving Chemotherapy
  • 5 Fraction Stereotactic Body Radiation Therapy for Oligometastases Regimen, for Extra-Cranial Oligometastases
  • Phase I Dose Finding Study for Melatonin in Pediatric Oncology Patients With Relapsed Solid Tumours
  • Dose Escalation Study of CyberKnife® SBRT Boost for Patients With Unresectable Locally Advanced Pancreatic Cancer
  • A Phase 2 Biomarker - Enriched Study of TH-302 in Subjects With Advanced Melanoma
  • Study Comparing the Efficacy of MEK162 Versus Dacarbazine in Unresectable or Metastatic NRAS Mutation-positive Melanoma
  • Phase 3 Frontline Therapy Trial in Patients With Advanced Classical Hodgkin Lymphoma
  • A Study of MK-1775 in Combination With Cisplatin and Radiation in Cervical Cancer
  • Long Term Results of the Canadian Breast IMRT Study
  • Busulfan & Melphalan Conditioning for Autologous Stem Cell Transplant (ASCT) and Lenalidomide Maintenance
  • A Study of Cisplatin With or Without MK-1775 in Squamous Cell Cancer of the Head and Neck
  • Cabozantinib-S-Malate in Treating Patients With Recurrent or Metastatic Endometrial Cancer
  • Romidepsin, Gemcitabine, Dexamethasone and Cisplatin in the Treatment of Peripheral T-Cell and Diffuse Large B-Cell Lymphoma
  • MRI FDG PET Imaging Cervix
  • Stepped Care Model for the Wider Dissemination of Cognitive-Behavioural Therapy for Insomnia Among Cancer Patients : Efficacy and Cost-Effectiveness
  • Irinotecan Hydrochloride and Temozolomide With Temsirolimus or Monoclonal Antibody Ch14.18 in Treating Younger Patients With Refractory or Relapsed Neuroblastoma
  • Comparison of 20% Mannitol and 3% Hypertonic Saline for Cerebral Relaxation During Elective Supratentorial Craniotomies
  • Preoperative Biliary Drainage
  • Pilot Study of Living With Hope Program
  • Rituxan INF II
  • Efficacy and Safety of Idelalisib (GS-1101) in Combination With Bendamustine and Rituximab for Previously Treated Indolent Non-Hodgkin Lymphomas
  • IXAZOMIB Plus Lenalidomide and Dexamethasone Versus Placebo Plus Lenalidomide and Dexamethasone in Adult Patients With Newly Diagnosed Multiple Myeloma
  • A Study of ARN-509 in Men With Non-Metastatic Castration-Resistant Prostate Cancer
  • Olaparib Treatment in BRCA Mutated Ovarian Cancer Patients After Complete or Partial Response to Platinum Chemotherapy
  • Blood Sample Markers of Reproductive Hormones in Assessing Ovarian Reserve in Younger Patients With Newly Diagnosed Lymphomas
  • Study to Assess the Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine in Adults Aged 18 Years and Older With Blood Cancers
  • Barrier Film vs. Standard Skin Care in Preventing Dermatitis in Women With Breast Cancer Receiving Radiation
  • Olaparib Monotherapy in Patients With BRCA Mutated Ovarian Cancer Following First Line Platinum Based Chemotherapy.
  • Combination Study of Deferasirox and Erythropoietin in Patients With Low- and Int-1-risk Myelodysplastic Syndrome.
  • Pharmacokinetics and Safety of Regorafenib (BAY73-4506) in Cancer Subjects With Severe Renal Impairment
  • Phase 3 Trial of Autologous Dendritic Cell Immunotherapy (AGS-003) Plus Standard Treatment of Advanced Renal Cell Carcinoma (RCC)
  • Study of Efficacy and Safety of Buparlisib (BKM120) Plus Paclitaxel Versus Placebo Plus Paclitaxel in Recurrent or Metastatic Head and Neck Cancer Previously Pre-treated With a Platinum Therapy
  • A Study of the Bruton's Tyrosine Kinase Inhibitor, PCI-32765 (Ibrutinib), in Combination With Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With Newly Diagnosed Non-Germinal Centre B-Cell Subtype of Diffuse Large B-Cell Lymphoma
  • Study Comparing Combination of LGX818 Plus MEK162 and LGX818 Monotherapy Versus Vemurafenib in BRAF Mutant Melanoma
  • Evaluate Risk/Benefit of Nab Paclitaxel in Combination With Gemcitabine and Carboplatin Compared to Gemcitabine and Carboplatin in Triple Negative Metastatic Breast Cancer (or Metastatic Triple Negative Breast Cancer)
  • ASG-15ME is a Study of Escalating Doses of AGS15E Given as Monotherapy in Subjects With Metastatic Urothelial Cancer
  • A Study of Rucaparib in Patients With Platinum-Sensitive, Relapsed, High-Grade Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (ARIEL2)
  • Assess Efficacy & Safety of Selumetinib in Combination With Docetaxel in Patients Receiving 2nd Line Treatment for v-Ki-ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Positive NSCLC
  • Study Comparing AEZS-108/ZoptEC (Zoptarelin Doxorubicin in Endometrial Cancer) to Doxorubicin as a Second Line Therapy of Endometrial Cancer
  • A Phase 3 Study of Ganetespib in Combination With Docetaxel Versus Docetaxel Alone in Patients With Advanced NSCLC
  • Efficacy and Safety Study of ABP 980 Compared With Trastuzumab in Subjects With HER2 Positive Early Breast Cancer
  • A Phase 2 of GS-9973 in Subjects With Relapsed or Refractory Hematologic Malignancies
  • Palbociclib (PD-0332991) Combined With Fulvestrant In Hormone Receptor+ HER2-Negative Metastatic Breast Cancer After Endocrine Failure (PALOMA-3)
  • Efficacy of Oral Azacitidine Plus Best Supportive Care as Maintenance Therapy in Subjects With Acute Myeloid Leukemia in Complete Remission
  • Stereotactic Body Radiation Therapy Versus Conventional Radiation Therapy in Medically-Inoperable Non-Small Lung Cancer Patients
  • AML-MDS Novel Prognostic Tests Clinical Study
  • Comparison of qPCR to IHC and FISH for Detection of ALK Fusion Mutations in FFPE Tissue From NSCLC Patients
  • A Phase 2 Study of MPDL3280A (an Engineered Anti-PDL1 Antibody) in Patients With PD-L1 Positive Locally Advanced or Metastatic Non-Small Cell Lung Cancer - "BIRCH"
  • Study of Trametinib in Advanced Cancer Patients With Hepatic Dysfunction
  • The PREPAReS Study: Pathogen Reduction Evaluation & Predictive Analytical Rating Score.
  • A Randomized, Double-blind, Phase 3 Efficacy Trial of PROSTVAC-V/F +/- GM-CSF in Men With Asymptomatic or Minimally Symptomatic Metastatic Castrate-Resistant Prostate Cancer
  • Afatinib in Patients With Non Small Cell Lung Cancer (NSCLC) With Epidermal Growth Factor Receptor (EGFR) Mutations
  • Trial of Pimasertib With SAR245409 or Placebo in Ovarian Cancer
  • Observation in Patients With Early-Stage Vulvar Cancer Following Surgery and/or Radiation Therapy
  • Trial of Preoperative Therapy for Gastric and Esophagogastric Junction Adenocarcinoma (TOPGEAR)
  • A Study of MEK162 vs. Physician's Choice Chemotherapy in Patients With Low-grade Serous Ovarian, Fallopian Tube or Peritoneal Cancer
  • A Study of Cabozantinib (XL184) vs Everolimus in Subjects With Metastatic Renal Cell Carcinoma
  • Pomalidomide (POM) in Combination With Low Dose Dexamethasone (LD-Dex) in Patients With Relapsed or Refractory Multiple Myeloma
  • COlorectal Cancer Treated With Adjuvant Regorafenib Versus Placebo After Curative Treatment of Liver Metastases in a Randomized, Double-blind, Placebo‑Controlled Phase-III STudy
  • A Study of Neratinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in Patients With HER2+ Metastatic Breast Cancer Who Have Received Two or More Prior HER2 Directed Regimens in the Metastatic Setting
  • Hormone Therapy Or Chemotherapy Before Surgery Based on Gene Expression Analysis in Treating Patients With Breast Cancer
  • A Phase III Study of BKM120 With Fulvestrant in Patients With HR+,HER2-, AI Treated, Locally Advanced or Metastatic Breast Cancer Who Progressed on or After mTORi
  • A Safety Study of Obinutuzumab Alone or in Combination With Chemotherapy in Patients With Chronic Lymphocytic Leukemia
  • Feasibility Study of Stereotactic Body Radiation Therapy for Early Breast Cancer
  • Standard Versus Intensity-Modulated Pelvic Radiation Therapy in Treating Patients With Endometrial or Cervical Cancer
  • Sorafenib Tosylate With or Without Stereotactic Body Radiation Therapy in Treating Patients With Liver Cancer
  • A Study of CFI-400945 Fumarate in Patients With Advanced Cancer
  • Chemotherapy Alone or Chemotherapy Plus Radiation Therapy in Treating Patients With Locally Advanced Rectal Cancer Undergoing Surgery
  • The Efficacy and Safety of Oral Azacitidine Plus Best Supportive Care Versus Placebo and Best Supportive Care in Subjects With Red Blood Cell (RBC) Transfusion-Dependent Anemia and Thrombocytopenia Due to International Prognostic Scoring System (IPSS) Low Risk Myelodysplastic Syndrome (MDS)
  • Relating Clinical Outcomes in Multiple Myeloma to Personal Assessment of Genetic Profile
  • Trial Comparing Nab-Paclitaxel to Paclitaxel in Patients With Advanced Urothelial Cancer Progressing on or After Platinum Containing Regimen.
  • Study to Determine the Efficacy of Regorafenib in Metastatic Colorectal Cancer Patients and to Discover Biomarkers
  • A Study of Kadcyla (Trastuzumab Emtansine) Plus Perjeta (Pertuzumab) Following Anthracyclines in Comparison With Herceptin (Trastuzumab) Plus Perjeta and a Taxane Following Anthracyclines as Adjuvant Therapy in Patients With Operable HER2-Positive Primary Breast Cancer
  • EBUS/Spectrum Analysis
  • SABR Including Regional Lymph Node Irradiation for Patients With High Risk Prostate Cancer (SATURN)
  • Phase Ib/II Study of Buparlisib Plus Carboplatin or Lomustine in Patients With Recurrent Glioblastoma Multiforme
  • MK-1775, Cisplatin, and Radiation Therapy in Treating Patients With Cervical Cancer
  • Effects of Vitamin D in Patients With Breast Cancer
  • Technique for Localization of Pulmonary Nodules Using Spy Thoracoscope System
  • Prospective Study Determining the Pain Response, Functional Interference and Quality of Life in Patients Undergoing Radiofrequency Ablation Assisted Vertebroplasty/ Cementoplasty
  • AZD8186 First Time In Patient Ascending Dose Study
  • A Safety and Efficacy Study of Eltrombopag in Subjects With AML
  • A Study of BBI608 in Combination With Standard Chemotherapies in Adult Patients With Advanced Gastrointestinal Cancer
  • Gadofosveset Trisodium (Ablavar, Gdfos) in Distinguishing Hemangiomas and Metastases: A Prospective Trial
  • GTN Therapy on Biomarkers of Immune Escape in Men With Biochemical Recurrence of Prostate Cancer After Primary Therapy
  • Phase I/II Study of Nilotinib/Ruxolitinb Therapy for TKI Resistant Ph-Leukemia
  • Standard of Care +/- Midostaurin to Prevent Relapse Post Stem Cell Transplant in Patients With FLT3-ITD Mutated AML
  • Ruxolitinib in the Treatment of Chronic Lymphocytic Leukemia
  • Two StereoTactic Ablative Adaptive Radiation Therapy Treatments for Localized Prostate Cancer
  • Prostatectomy Adaptive Radiation Therapy (ART)
  • A Phase 1/2 Study to Evaluate MEDI4736
  • Predictive Biomarkers For Pediatric Chronic Graft-Versus-Host Disease
  • TELESTAR (Telotristat Etiprate for Somatostatin Analogue Refractory Carcinoid Syndrome)
  • Safety Study of Thioridazine in Combination With Cytarabine to Treat Relapsed or Refractory Acute Myeloid Leukemia
  • A Study Of PF-05212384 In Combination With Other Anti-Tumour Agents
  • A Phase I Trial to Assess the Effects of Food and Formulation on PK of KPT-330 in Patients With Sarcoma
  • Accuracy of Sentinel Lymph Node Biopsy and Gadofosveset-Enhanced MR in Nodal Staging of High Risk Endometrial Cancer
  • Whole-Brain Radiation Therapy With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
  • Phase 1b Trial of BGJ398/BYL719 in Solid Tumours
  • Study Using Combined Virtual 4-D Electromagnetic (EM) Tip-Tracked Devices & EBUS in Diagnosis of Lung Nodules
  • A 2 Part, Phase 2 Trial of Galeterone in the Treatment of Castration Resistant Prostate Cancer
  • Open-Label Study Evaluating Dasatinib Therapy Discontinuation in Patients With Chronic Phase Chronic Myeloid Leukemia With Stable Complete Molecular Response
  • Phase Ib/II Study of Efficacy and Safety of MEK162 and Panitumumab, in Adult mCRC Patients With Mutant or Wild-type RAS Tumours
  • Apixaban for the Prevention of Venous Thromboembolism in Cancer Patients
  • Comparison of Percutaneous Image-guided Gastrostomies
  • Feasibility Trial Of Image Guided External Beam Radiation Therapy With Or Without High Dose Rate Brachytherapy Boost In Men With Intermediate-Risk Prostate Cancer
  • Standard or Comprehensive Radiation Therapy in Treating Patients With Early-Stage Breast Cancer Previously Treated With Chemotherapy and Surgery
  • Safety and Efficacy Study of Enzalutamide in Patients With Nonmetastatic Castration-Resistant Prostate Cancer
  • A Maintenance Study With Niraparib Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer
  • Outcomes of HCC (Hepatocellular Carcinoma) Patients Treated With TACE (Transarterial Chemoembolization) and Early, Not Early or Not at All Followed by Sorafenib
  • Busulfan, Cyclophosphamide, and Melphalan or Busulfan and Fludarabine Phosphate Before Donor Hematopoietic Cell Transplant in Treating Younger Patients With Juvenile Myelomonocytic Leukemia
  • Phase 3 Study of Carfilzomib, Melphalan, Prednisone vs Bortezomib, Melphalan, Prednisone in Newly Diagnosed Multiple Myeloma (CLARION)
  • Cyclophosphamide, Topotecan, and Bevacizumab (CTB) in Patients With Relapsed/Refractory Ewing's Sarcoma and Neuroblastoma
  • Safety and Efficacy of Buparlisib (BKM120) in Patients With Untreated Squamous Non-small Cell Lung Cancer
  • MRI Brain Mets Breast (FIESTA)
  • Abdominal Massage for Relief of Small Bowel Obstruction
  • Neurocognition After Gamma Knife Radiosurgery for Multiple Brian Metastases
  • Functional MR-guided Stereotactic Body Radiation Therapy of Prostate Cancer
  • Study to Evaluate Real-world Pharmacoeconomics of Panitumumab in Metastatic Colorectal Cancer Patients
  • A Randomized Study of DNIB0600A in Comparison With Pegylated Liposomal Doxorubicin in Patients With Platinum-Resistant Ovarian Cancer
  • A Study of Rucaparib as Switch Maintenance Following Platinum-Based Chemotherapy in Patients With Platinum-Sensitive, High-Grade Serous or Endometrioid Epithelial Ovarian, Primary Peritoneal or Fallopian Tube Cancer
  • A Study of the Experimental Drug BKM120 With Paclitaxel in Patients With HER2 Negative, Locally Advanced or Metastatic Breast Cancer, With or Without PI3K Activation
  • An Open-Label, Randomized, Phase 3 Trial of Nivolumab Versus Investigator's Choice Chemotherapy as First-Line Therapy for Stage IV or Recurrent PD-L1+ Non-Small Cell Lung Cancer (CheckMate 026)
  • Cytarabine and Daunorubicin Hydrochloride or Idarubicin and Cytarabine With or Without Vorinostat in Treating Younger Patients With Previously Untreated Acute Myeloid Leukemia
  • A Safety and Biodistribution Study of [I-124]-CPD-1028 Injection in Solid Tumours
  • A Phase 1B Study to Investigate the Safety and Preliminary Efficacy for the Combination of Dasatinib Plus Nivolumab in Patients With Chronic Myeloid Leukemia
  • Study of Efficacy and Safety of LEE011 in Postmenopausal Women With Advanced Breast Cancer.(MONALEESA-2)
  • Lenalidomide and Ibrutinib in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma
  • Caspofungin Acetate, Fluconazole, or Voriconazole in Preventing Fungal Infections in Patients Following Donor Stem Cell Transplant
  • Neoadjuvant Finasteride for Patients With Non-small Cell Lung Cancer
  • Relationship Stressors in Parents of Children With Cancer
  • A Trial to Assess the Safety and Effectiveness of Lutetium-177 Octreotate Therapy in Neuroendocrine Tumours
  • Study of the Pharmacokinetics and Safety of Carfilzomib in Subjects With Multiple Myeloma and Renal Disease
  • A Dose Escalation Study Evaluating the Safety and Tolerability of GDC-0032 in Patients With Locally Advanced or Metastatic Solid Tumours And in Combination With Endocrine Therapy in Patients With Locally Advanced or Metastatic Hormone Receptor-Positive Breast Cancer
  • Surgery With or Without Radiation Therapy in Treating Patients With Previously Untreated Nonmetastatic Retroperitoneal Soft Tissue Sarcoma
  • Bortezomib and Sorafenib Tosylate in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
  • GSK1120212 Rollover Study
  • Sunitinib or Cediranib for Alveolar Soft Part Sarcoma
  • Prophylactic Antibiotic Regimens in Tumour Surgery (PARITY): Pilot Study
  • Methotrexate or Dactinomycin in Treating Patients With Low-Risk Gestational Trophoblastic Neoplasia
  • SC-PEG Asparaginase vs. Oncaspar in Pediatric Acute Lymphoblastic Leukemia (ALL) and Lymphoblastic Lymphoma
  • Safety Study of the Selective Inhibitor of Nuclear Export (SINE) KPT-330 in Patients With Advanced Hematological Cancer
  • Neratinib in Metastatic HER2 Non-amplified But HER2 Mutant Breast Cancer
  • A Study of Drug Therapies for Salivary Gland Cancers Based on Testing of Genes
  • Dinaciclib and Akt Inhibitor MK2206 in Treating Patients With Pancreatic Cancer That Cannot Be Removed By Surgery
  • Safety and Efficacy of Donor T-lymphocytes Depleted ex Vivo of Host Alloreactive T-cells (ATIR) in Patients With a Hematologic Malignancy Who Received a Hematopoietic Stem Cell Transplantation From a Haploidentical Donor
  • Study to Allow Access to Pasireotide for Patients Benefiting From Pasireotide Treatment in a Novartis-sponsored Study.
  • Preventing Cardiac Sequelae in Pediatric Cancer Survivors
  • Decision Support Workshop for Breast Reconstruction
  • Dabrafenib in Treating Patients With Solid Tumours and Kidney or Liver Dysfunction
  • N-PhenoGENICS: Neurocognitive-Phenome, Genome, Epigenome and Nutriome In Childhood Leukemia Survivors
  • WEE1 Inhibitor MK-1775 and Local Radiation Therapy in Treating Younger Patients With Newly Diagnosed Diffuse Intrinsic Pontine Gliomas
  • The Neuro-protective Effects of Exercise in Children With Brain Tumours
  • Pilot Study of Perindopril in Childhood Cancer Survivors
  • Oral Iron vs. Placebo in Newly Diagnosed Gynecologic Oncology Patients Who Are Surgical Candidates.
  • Placebo Controlled Study of VS-6063 in Subjects With Malignant Pleural Mesothelioma
  • To Find a Safe Dose and Show Early Clinical Activity of Weekly Nab-paclitaxel in Pediatric Patients With Recurrent/ Refractory Solid Tumours
  • A Phase I/II, Multicentre, Open-label Study of EGFRmut-TKI EGF816, Administered Orally in Adult Patients With EGFRmut Solid Malignancies
  • Healthy Bones Study
  • A Phase 1b Study of ONT-380 Combined With Ado-trastuzumab Emtansine (T-DM1) in Patients With HER2+ Breast Cancer
  • Phase I Ascending Multiple-Dose Study of BMS-986115 in Subjects With Advanced Solid Tumours
  • HAIP-6192
  • Novel Window of Opportunity Trial to Evaluate the Impact of Statins to Oppose Prostate Cancer
  • 18F-FCH (Fluorocholine)-PET/MR in Staging of High-Risk Prostate Cancer
  • Study of Glembatumumab Vedotin (CDX-011) in Patients With Metastatic, gpNMB Over-Expressing, Triple Negative Breast Cancer
  • A Study to Compare the Safety and Efficacy of an Aromatase Inhibitor in Combination With Lapatinib, Trastuzumab or Both for the Treatment of Hormone Receptor Positive, HER2+ Metastatic Breast Cancer
  • Automated Breast Radiation Therapy Using an MR-Guided Process
  • Stereotactic Radiation Therapy for Metastatic Kidney Cancer Being Treated With Sunitinib
  • Placebo Controlled Double Blind Crossover Trial of Metformin for Brain Repair in Children With Cranial-Spinal Radiation for Medulloblastoma
  • Strategies to Improve Bone Health in Men on ADT
  • A Phase II Trial Testing Oral Administration of Lucitanib in Patients With Fibroblast Growth Factor Receptor (FGFR)1-amplified or Non-amplified Estrogen Receptor Positive Metastatic Breast Cancer
  • A Safety and Feasibility Study of Mitotane in Prostate Cancer
  • A Study of Nivolumab and Nivolumab Plus Ipilimumab in Recurrent and Metastatic Colon Cancer (CheckMate 142)
  • Trametinib in Treating Patients With Advanced Cancer With or Without Hepatic Dysfunction
  • Preoperative Imaging in DIEP Flap Breast Reconstruction
  • The Effect of an Inter-Disciplinary Program, Including MBSR, in Breast Cancer Survivors With Chronic Neuropathic Pain
  • Acupuncture for Lymphedema Secondary to Breast Cancer Treatment
  • Allogeneic SCT for CML, TKI Failure After TKI Failure
  • Imaging of High Grade Prostate Cancer
  • Cisplatin With or Without WEE1 Inhibitor MK-1775 in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
  • Prostate Screening Study Using MRI in BRCA Carriers
  • Standard Dose Versus High Dose and Versus Extended Standard Dose Radium-223 Dichloride in Castration-resistant Prostate Cancer Metastatic to the Bone
  • Evaluation of SAR408701 in Patients With Advanced Solid Tumours
  • Efficacy of Combination Listeria/GVAX Immunotherapy in the Pancreatic Cancer Setting
  • Novel Combinations of CC-122, CC-223, CC-292, and Rituximab in Diffuse Large B-cell Lymphoma
  • Prehabilitation for Prostate Cancer Surgery
  • Evolution® Biliary Stent System-Fully Covered
  • 18F-FCH PET/MRI to Assess Tumour Response in Castration Resistant Prostate Cancer
  • Yoga Fatigue Study
  • A Phase II Trial Measuring the Integration of Stereotactic Radiation Therapy Plus Surgery in Early Non-Small Cell Lung Cancer
  • Incentive Spirometry Added to Physiotherapy to Reduce Postoperative Pulmonary Complications After Lung Surgery
  • Does Intense Regimented Surveillance Improve the Rates of Therapeutic Re-Intervention After Lung Cancer Surgery
  • A Feasibility Study for Women Receiving Anthracycline Chemotherapy With or Without Radiation for HER2-neu Positive Invasive Ductal Carcinoma
  • Pazopanib Hydrochloride in Treating Patients With Progressive Carcinoid Tumours
  • Study of Nivolumab in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL) That Have Either Failed or Are Not Eligible for Autologous Stem Cell Transplant (CheckMate 139)
  • Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
  • Study to Evaluate the Safety and Tolerability of BMS-906024 in Combination With Chemotherapy (Weekly Paclitaxel, 5FU Plus Irinotecan (FOLFIRI) or Carboplatin Plus Paclitaxel) in Subjects With Advanced or Metastatic Solid Tumours
  • Cabazitaxel in Pediatric Patients With Refractory Solid Tumours Including Central Nervous System Tumours
  • LGX818 in Combination With Agents (MEK162; BKM120; LEE011; BGJ398; INC280) in Advanced BRAF Melanoma
  • A Study of Continuous Avastin (Bevacizumab) Treatment in Combination With Standard of Care Following Disease Progression in Patients With Glioblastoma
  • Paravertebral Blocks for Breast Cancer Surgery
  • A Study of ENMD-2076 in Ovarian Clear Cell Cancers
  • A Study of Trametinib and GSK2141795 Multiple Myeloma
  • Study to Evaluate Treatment of Dabrafenib Plus Trametinib in Subjects With BRAF Mutation-Positive Melanoma That Has Metastasized to the Brain
  • A Study to Assess the Efficacy and Safety of Enzalutamide With Trastuzumab in Subjects With Human Epidermal Growth Factor Receptor 2 Positive (HER2+), Androgen Receptor Positive (AR+) and Estrogen Receptor Negative (ER-) Metastatic or Locally Advanced Breast Cancer
  • Denosumab in Combination With Chemotherapy as First-line Treatment of Metastatic Non-small Cell Lung Cancer
  • Trametinib and Akt Inhibitor GSK2141795 in Treating Patients With Relapsed or Refractory Multiple Myeloma
  • I-Scan Vs High Definition White Light (Main Study)
  • Phase 2 Study of AMG 337 in MET Amplified Gastric/Esophageal Adenocarcinoma or Other Solid Tumours
  • Does the Harmonic Scalpel Reduce Blood Loss and OR Time in Major Head and Neck Cancer Surgery Undergoing Major Surgery for Oral Cavity Squamous Cell Carcinoma?
  • A Study to Collect Survival Data on Patients Previously Enrolled in Abraxane Pancreatic Cancer Study CA046.
  • An Exercise Trial and Economic Analysis in Men With Prostate Cancer
  • A Study to See Whether Breath-Hold Techniques During Radiation Treatment Are Effective in Helping to Improve Sparing of the Heart
  • AA Study of Escalating Doses of ASG-22CE Given as Monotherapy in Subjects With Metastatic Urothelial Cancer and Other Malignant Solid Tumours That Express Nectin-4
  • Correlative Biomarker Study in Patients With Myeloproliferative Disorders
  • A Feasibility Trial of Geriatric Assessment and Management for Older Cancer Patients
  • Efficacy and Safety of Idelalisib in Combination With Bendamustine and Rituximab in Subjects With Previously Untreated Chronic Lymphocytic Leukemia
  • Tranexamic Acid During Cystectomy Trial (TACT) Pilot Study
  • A Study of GDC-0199 (ABT-199) Plus MabThera/Rituxan (Rituximab) Compared With Bendamustine Plus MabThera/Rituxan (Rituximab) in Patients With Relapsed or Resistant Chronic Lymphocytic Leukemia
  • Investigation of the Anti-Cancer Activity of Artichoke Extract in an Asbestos-Exposed Population
  • Strength Training Study for Survivors of Breast and Gynecologic Cancer
  • Efficacy and Safety Study of ABP 215 Compared With Bevacizumab in Subjects With Advanced Non-Small Cell Lung Cancer
  • Phase IIb Study of Dasatinib Versus Imatinib in Patients With CML-CP Who Have Not Achieved an Early Optimal Response to Imatinib
  • Oral Pacritinib Versus Best Available Therapy to Treat Myelofibrosis With Thrombocytopenia
  • A Study Of PF-05212384 Plus FOLFIRI Versus Bevacizumab Plus FOLFIRI In Metastatic Colorectal Cancer
  • A Study of MPDL3280A in Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer
  • A Feasibility Study of an Online Intervention for Sexual Rehabilitation in Prostate Cancer
  • Study to Evaluate Real-world Pharmacoeconomics and Resistance Mechanisms of Panitumumab in Metastatic Colorectal Cancer Patients
  • Study to Identify Biomarkers of Clinical Response to Aflibercept in Patients With Metastatic Colorectal Cancer
  • A Study To Evaluate PF-04449913 With Chemotherapy In Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
  • A Multicentre Phase 3, Open-Label Study of Bosutinib Versus Imatinib in Adult Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia
  • Study to Evaluate Resistance Mechanisms and Real-world Pharmacoeconomics of Crizotinib in NSCLC Patients
  • Randomized, Double-Blind, Multicentre, Study Comparing Veliparib Plus Carboplatin and Paclitaxel Versus Placebo Plus Carboplatin and Paclitaxel in Previously Untreated Advanced or Metastatic Squamous Non-Small Cell Lung Cancer
  • Randomized, Double-blind Study Comparing Tremelimumab to Placebo in Subjects With Unresectable Malignant Mesothelioma
  • This Trial is a Randomized, Open-label Two-arm Phase III Comparative Study Assessing the Role of Involved Mediastinal Radiation Therapy After Rituximab Containing Chemotherapy Regimens to Patients With Newly Diagnosed Primary Mediastinal Large B-Cell Lymphoma
  • Study of Cabozantinib (XL184) vs Placebo in Subjects With Hepatocellular Carcinoma Who Have Received Prior Sorafenib
  • A Study for Patients With Prostate Cancer to See Whether Delivering an Extra Dose of Radiation to Parts of the Body With More Cancer is Better Than Standard Treatment in Which the Same Dose of Radiation is Given Throughout the Prostate Gland
  • Advanced Lung Cancer Treatment With Metformin and Chemo-Radiotherapy
  • Use of Exome Sequence Analysis and Circulating Tumour in Assessing Tumour Heterogeneity in BRAF Mutant Melanoma
  • A Study Evaluating Perjeta (Pertuzumab) Combined With Herceptin (Trastuzumab) and Standard Anthracycline-based Chemotherapy in Patients With HER2-positive Locally Advanced, Inflammatory, or Early-stage Breast Cancer.
  • Extended Out-of-hospital Low-molecular-weight Heparin Prophylaxis Against DVT and PE in Patients Undergoing Major Lung Resection
  • Carfilzomib, Lenalidomide, and Dexamethasone Before and After Stem Cell Transplant in Treating Patients With Newly Diagnosed Multiple Myeloma
  • A Phase I Evaluating Integration of HypofractionatedStudy Renal Ablative Radiation Therapy
  • Risk-Based Therapy in Treating Younger Patients With Newly Diagnosed Liver Cancer
  • Brief Intraoperative Electrical Stimulation for Prevention of Shoulder Dysfunction After Oncologic Neck Dissection